Загрузка...
Serum creatinine elevation after switch to dolutegravir in a human immunodeficiency virus-positive kidney transplant recipient
Dolutegravir is a preferred antiretroviral drug for human immunodeficiency virus (HIV)-infected patients following solid organ transplantation. It has potent antiretroviral activity and does not interact with calcineurin inhibitors. We describe a case of an HIV-infected kidney transplant patient, wh...
Сохранить в:
| Опубликовано в: : | Transpl Infect Dis |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5525135/ https://ncbi.nlm.nih.gov/pubmed/27159656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.12545 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|